Companies on the list are subject to a series of sanctions, including import and export control restrictions, barred business activities in China, and fines.
Cancer Immunotherapy Response Linked to Gut Microbes in Multiomic Analysis
Researchers found gut microbes and metabolites linked to pan-cancer immune checkpoint blockade responses, highlighting five distinct enterotypes.
The method combines MERFISH with expansion microscopy to increase the volume of individual bacterial cells and reduce the density of RNA molecules inside.
US Patent Review Panel Invalidates 10x Genomics' Patent Claims After Parse Biosciences Challenge
Parse Biosciences, which has now triggered invalidation of three 10x Genomics patents in response to being sued for infringement, said it was a "significant legal victory."
The company reported a 5 percent increase in Q4 2024 revenues and flat full-year revenues, but guided for 3 percent to 4 percent organic revenue growth in 2025.
Twist Bioscience Raises Fiscal 2025 Guidance as Q1 Revenues Rise 24 Percent
The synthetic biology and genomics company reported 24 percent year-over-year revenue growth in fiscal Q1, beating Wall Street expectations.